Hypertension and Diabetes Initiative - Improving Hypertension Control in Individuals With Diabetes
Improving Hypertension Control in Individuals With Diabetes
1 other identifier
observational
11,510
0 countries
N/A
Brief Summary
Twelve health organizations from around the US were selected to participate in a chart review Hypertension and Diabetes Initiative with the goal of improving blood pressure control in persons with diabetes. Hypothesis: A three-phase quality improvement initiative facilitated and monitored through the International Diabetes Center (IDC) will result in improved population-mean systolic blood pressure in the aggregate data pool of patients from all 12 participating sites at geographically distinct health systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2006
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 9, 2008
CompletedFirst Posted
Study publicly available on registry
August 29, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2010
CompletedDecember 2, 2015
August 1, 2013
1.4 years
June 9, 2008
November 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Systolic blood pressure
1 year
Secondary Outcomes (1)
Measure changes in action taken related to improving blood pressure management as percent of providers reporting changing (initiating or adjusting) blood pressure medication
1 year
Interventions
3-phase quality improvement intervention
Eligibility Criteria
Primary care clinic
You may qualify if:
- ICD-9 Code 250 (indicates type 1 or type 2 diabetes)
- ICD- Code 648.0 (indicates pregnancy with type 1 or type 2 diabetes)
- ICD-9 Code 357.2 or 362.0, indicating complications of diabetes.
- A prescription for insulin or oral hypoglycemic agents
- Include those 18-75 years
You may not qualify if:
- Attend a dialysis unit (if the nephrologist is primary care manager)
- Have gestational diabetes (ICD-9 Code 648.8)
- Have a terminal illness (e.g., hospice patient)
- Do not have a documented blood pressure within the past year (this is asked on the audit form)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- HealthPartners Institutelead
- Advocate Medical Groupcollaborator
- Baystate Healthcollaborator
- Corewell Health Eastcollaborator
- Columbia Park Medical Groupcollaborator
- Humboldt Del Norte Independent Practice Associationcollaborator
- Metropolitan Healthcollaborator
- Park Nicollet Cliniccollaborator
- PeaceHealth Medical Groupcollaborator
- Sanford Cliniccollaborator
- TriHealth Inc.collaborator
- University Hospitals Medical Practicescollaborator
- Warren Cliniccollaborator
- Novartiscollaborator
Related Publications (5)
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group; Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000 Feb 10;342(6):381-9. doi: 10.1056/NEJM200002103420603.
PMID: 10666428BACKGROUNDChobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14.
PMID: 12748199BACKGROUNDSaaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, Narayan KM. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006 Apr 4;144(7):465-74. doi: 10.7326/0003-4819-144-7-200604040-00005.
PMID: 16585660BACKGROUNDAdler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000 Aug 12;321(7258):412-9. doi: 10.1136/bmj.321.7258.412.
PMID: 10938049BACKGROUNDMajor cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA. 2000 Apr 19;283(15):1967-75.
PMID: 10789664BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret A Powers, PhD
International Diabetes Center - Park Nicollet Institute
- PRINCIPAL INVESTIGATOR
Robert M Cuddihy, MD
International Diabetes Center - Park Nicollet Institute
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2008
First Posted
August 29, 2008
Study Start
December 1, 2006
Primary Completion
May 1, 2008
Study Completion
September 1, 2010
Last Updated
December 2, 2015
Record last verified: 2013-08